In other cancer types, including breast cancer, miR-26a was found to block tumour cell growth and invasion by targeting tumour-promoting targets such as family with sequence similarity 98 member A (FAM98A) in vitro [65]. This evidence concerns the gene TSLIG3A and breast carcinoma.